Key result
Endothelial 5-HT1B inhibition attenuates disturbed flow-induced inflammation and atherogenesis in preclinical models.
Answers are grounded in this paper and cite their sources.
Endothelial 5-HT1B acts as a mechanosensor for disturbed flow, and its inhibition suppresses endothelial activation and atherogenesis, identifying it as a potential therapeutic target for atherosclerosis.
BACKGROUND: Atherosclerosis is characterized by the accumulation of fatty and fibrotic plaques, which preferentially develop at curvatures and branches along the arterial trees that are exposed to disturbed flow. However, the mechanisms by which endothelial cells sense disturbed flow are still unclear. METHODS: The partial carotid ligation mouse model was used to investigate disturbed flow-induced atherogenesis. In vitro experiments were performed using the ibidi system to generate oscillatory shear stress and laminar shear stress. ApoE −/− mice with endothelium-specific knockout or overexpression of 5-HT 1B (serotonin receptor 1B) were used to investigate the role of endothelial 5-HT 1B in atherosclerosis. RNA sequencing analysis, immunofluorescence analysis, and molecular biological techniques were used to explore the role of 5-HT 1B in mechanotransduction and endothelial activation. RESULTS: The data showed that human endothelial cells express a high level of 5-HT 1B , which is a serotonin receptor subtype. Endothelial 5-HT 1B is upregulated in atherosclerotic areas of both humans and rodents and is increased by disturbed flow both in vivo and in vitro. Endothelium-specific overexpression of 5-HT 1B exacerbates, whereas knockout or knockdown of 5-HT 1B in endothelium inhibits disturbed flow-induced endothelial inflammation and atherogenesis in both male and female ApoE −/− mice. We reveal a previously unknown role of 5-HT 1B as a mechanosensor in endothelial cells in response to mechanical stimuli. Upon activation by oscillatory shear stress, 5-HT 1B recruits β-arrestin, orchestrates RhoA (ras homolog family member A), and then activates mechanosensitive YAP (yes-associated protein), thereby enhancing endothelial inflammation and monocyte infiltration. Pharmacological blockade of 5-HT 1B suppresses endothelial activation and atherogenesis via inhibition of YAP. CONCLUSIONS: Taken together, these results uncover that endothelial 5-HT 1B acts as a mechanosensor for disturbed flow and contributes to atherogenesis. Inhibition of 5-HT 1B could be a promising therapeutic strategy for atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied Atherosclerosis. Endothelium-specific knockout, knockdown, or overexpression of 5-HT1B, and pharmacological blockade vs. Control mice/cells was evaluated on Disturbed flow-induced endothelial inflammation and atherogenesis. Endothelial 5-HT1B acts as a mechanosensor for disturbed flow, where its overexpression exacerbates and its knockout or pharmacological blockade inhibits endothelial inflammation and atherogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: